BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8065163)

  • 1. Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulfoxide.
    Ryan JJ; Clarke MF
    Leuk Res; 1994 Aug; 18(8):617-21. PubMed ID: 8065163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of death of an erythroleukemic cell line by p53: involvement of the microtubule and mitochondria.
    Kato MV
    Leuk Lymphoma; 1999 Mar; 33(1-2):181-6. PubMed ID: 10194136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylsulfoxide-induced cell death of murine erythroleukemia cells exposed to ionising radiation.
    Di Pietro R; Centurione MA; Falcieri E; Centurione L; Santavenere E; Rana R
    Cell Signal; 1998 Mar; 10(3):205-9. PubMed ID: 9607144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
    Francastel C; Mazouzi Z; Robert-Lézénès J
    Leukemia; 1992 Sep; 6(9):935-9. PubMed ID: 1518304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.
    Abrahamson JL; Lee JM; Bernstein A
    Mol Cell Biol; 1995 Dec; 15(12):6953-60. PubMed ID: 8524262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of 5-methylcytosine removal from DNA of Friend erythroleukemia cells following exposure to several differentiating agents.
    Kuykendall JR; Cox R
    Cancer Lett; 1989 Sep; 47(1-2):149-52. PubMed ID: 2534571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of IW32 erythroleukemia cell differentiation by p53 is dependent on protein tyrosine phosphatase.
    Tang PP; Wang FF
    Leukemia; 2000 Jul; 14(7):1292-300. PubMed ID: 10914555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
    Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
    Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
    Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
    Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in p53 mRNA expression during terminal differentiation of murine erythroleukemia cells.
    Bendori R; Resnitzky D; Kimchi A
    Virology; 1987 Dec; 161(2):607-11. PubMed ID: 3318097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in proteinase activities during the differentiation of murine erythroleukemia cells.
    Tsukahara T; Ishiura S; Kominami E; Sugita H
    Exp Cell Res; 1990 May; 188(1):111-6. PubMed ID: 2184044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line.
    Kato MV; Sato H; Anzai H; Nagayoshi M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():389-92. PubMed ID: 9209401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-XL protects cancer cells from p53-mediated apoptosis.
    Schott AF; Apel IJ; Nuñez G; Clarke MF
    Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Prn-p gene and stable transfection of Prn-p cDNA in leukemia MEL and neuroblastoma N2a cells increased production of PrP(C) but not prevented DNA fragmentation initiated by serum deprivation.
    Gougoumas DD; Vizirianakis IS; Triviai IN; Tsiftsoglou AS
    J Cell Physiol; 2007 May; 211(2):551-9. PubMed ID: 17186498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
    Lo SC; Aft R; Mueller GC
    Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In malignant myeloid cells expression of Daxx downregulates expression of p53 and of the inhibitors of apoptosis proteins.
    Boehrer S; Nowak D; Schaaf S; Bergmann M; Brieger A; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Hematol J; 2004; 5(6):513-8. PubMed ID: 15570294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 protects murine erythroleukemia cells from p53-dependent and -independent radiation-induced cell death.
    Fukunaga-Johnson N; Ryan JJ; Wicha M; Nuñez G; Clarke MF
    Carcinogenesis; 1995 Aug; 16(8):1761-7. PubMed ID: 7634401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.